𝔖 Bobbio Scriptorium
✦   LIBER   ✦

ZD6474 – a novel inhibitor of VEGFR and EGFR tyrosine kinase activity

✍ Scribed by Ryan, A J; Wedge, S R

Book ID
109998524
Publisher
Nature Publishing Group
Year
2005
Tongue
English
Weight
189 KB
Volume
92
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-tumor activity of the combination o
Anti-tumor activity of the combination of cetuximab, an anti-EGFR blocking monoclonal antibody and ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinases
✍ Maria Pia Morelli; Tina Cascone; Teresa Troiani; Concetta Tuccillo; Roberto Bian 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB

## Abstract Purpose: The epidermal growth factor receptor (EGFR) autocrine pathway plays an important role in cancer cell growth. Vascular endothelial growth factor A (VEGF‐A) is a key regulator of tumor‐induced endothelial cell proliferation and vascular permeability. ZD6474 is an orally available

Induction of cell cycle arrest and apopt
Induction of cell cycle arrest and apoptosis in human nasopharyngeal carcinoma cells by ZD6474, an inhibitor of VEGFR tyrosine kinase with additional activity against EGFR tyrosine kinase
✍ Xia Xiao; Jiangxue Wu; Xiaofeng Zhu; Peng Zhao; Jinlin Zhou; Quentin Qiang Liu; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 849 KB

## Abstract ZD6474 is a vascular endothelial growth factor receptor (VEGFR) and epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor. The present study was undertaken to investigate the direct antiproliferative effect of ZD6474 on human nasopharyngeal carcinoma (NPC) __in vitro__ and t